Tenderwize
Back to tender search

Open house drug discount agreements Octreotide, ATC H01CB02

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Sep 03, 2027 · 383 days left·Open·Supplies·Framework
Sign up to saveOpen documents
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Octreotid, ATC H01CB02

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

Non-exclusivity and open entry may lead to many competitors, reducing per-company share

Automatic termination if other discount agreements (bundesweit or landesspezifisch) come into effect

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Oct 2027
  • Enter into non-exclusive discount agreements for Octreotide (ATC H01CB02) with all eligible pharmaceutical companies
Show full summary

Open-house model by AOK Bayern for non-exclusive discount agreements for Octreotide (ATC H01CB02). All eligible pharmaceutical companies can join by submitting signed documents. No competitive selection. Contracts run from 01.11.2025 to 31.10.2027 with rolling enrollment until 03.09.2027.

Risks

Non-exclusivity and open entry may lead to many competitors, reducing per-company share

Automatic termination if other discount agreements (bundesweit or landesspezifisch) come into effect

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company

Administrative

  • Submit signed declaration of reliability
  • Submit signed contract with annex listing drugs

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house drug discount agreements Octreotide, ATC H01CB02

Non-exclusive discount agreements for Octreotide (ATC H01CB02) under §130a Abs. 8 SGB V. All eligible pharmaceutical companies can participate. No selection.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Oct 2025 - Oct 2027

Category

Pharmaceutical products

Deadline

Deadline Sep 03, 2027

Procurement Details

Publication date
14 Sep 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
600472-2025

Documents (2)

Procurement document 1Submission portal 1

Similar tenders

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.

Sep 28

Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș

Sep 23
1 framework lot

France – Insurance services – MARCHE DE SERVICES EN ASSURANCE

Sep 30

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24